Tech Company Financing Transactions
3T Biosciences Funding Round
3T Biosciences closed a $12 million Seed investment round on 10/9/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/9/2017
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Investors
private investors (Lead Investor) (Sean Parker)
private investors (Peter Thiel)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
3T Biosciences is in the T-cell therapy space, meaning that it is among a growing group of new start-ups working to bolster the body's own immune system to fight cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Luke Lee
Browse more venture capital transactions:
Prev: 10/9/2017: NearGroup venture capital transaction
Next: 10/9/2017: Zenflow venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs